Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Thyreos logo — Prophylactic vaccines for neuroinvasive herpesviruses

Thyreos

Prophylactic vaccines for neuroinvasive herpesviruses

Founded 2017 5 employees Seed Health Care

General Information

Company Name Thyreos
Founded Year 2017
Employees 5
Industries Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Thyreos. To contact Thyreos, visit thyreosvaccines.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Thyreos compare?

A PDF of Thyreos and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Thyreos soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Thyreos

Thyreos is a startup that focuses on producing prophylactic vaccines for neuroinvasive herpesviruses. Founded in 2017, the company operates within the Health Care industry. Thyreos utilizes its R2 technology to provide safe and effective antigen delivery, aiming to generate robust immunity in both animals and humans. While the company's headquarters information and details about its last investment and investors are currently not available, Thyreos's dedication to addressing the critical need for vaccines in the area of neuroinvasive herpesviruses presents a promising opportunity for potential investors in the health sector.

No funding data available for Thyreos yet.

Thyreos Alternatives & Competitors

View All Alternatives
Thyreos vs
Mazen Animal Health - Oral Vaccines
Mazen Animal Health - Oral Vaccines United States

Game-changing animal disease prevention with orally-delivered, RT stable, cost effective vaccines fo...

Series A
21 employees
Biotechnology, Health Care
Thyreos vs
Intervacc AB
Intervacc AB Sweden

A new generation of vaccines based on fusions of recombinant proteins

Grant
13 employees
Biotechnology, Health Care
Thyreos vs
Belyntic GmbH
Belyntic GmbH Germany

The Precision Vaccines Company

Non Equity Assistance
2 employees
Biotechnology, Health Care
View all alternatives

FAQ About Thyreos

Prophylactic vaccines for neuroinvasive herpesviruses
Thyreos was founded in 2017.
Thyreos operates in Health Care.
Thyreos has approximately 5 employees.
Top alternatives and competitors to Thyreos include Mazen Animal Health - Oral Vaccines, Intervacc AB, Belyntic GmbH, Verovaccines, BlueWillow Biologics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Thyreos and Mazen Animal Health - Oral Vaccines are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Thyreos, https://bouncewatch.com/company/thyreos, updated 23 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes